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TherapyUsher syndrome (USH), clinically and genetically heterogeneous, is the leading genetic cause of combined
hearing and vision loss. USH is classiﬁed into three types, based on the hearing and vestibular symptoms
observed in patients. Sixteen loci have been reported to be involved in the occurrence of USH and atypical
USH. Among them, twelve have been identiﬁed as causative genes and one as amodiﬁer gene. Studies on the pro-
teins encoded by these USH genes suggest that USH proteins interact among one another and function in
multiprotein complexes in vivo. Although their exact functions remain enigmatic in the retina, USH proteins
are required for the development, maintenance and function of hair bundles, which are the primary
mechanosensitive structure of inner ear hair cells. Despite the unavailability of a cure, progress has been made
to develop effective treatments for this disease. In this review, we focus on the most recent discoveries in the
ﬁeld with an emphasis on USH genes, protein complexes and functions in various tissues as well as progress
toward therapeutic development for USH.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
In mammals, the inner ear and retina are the two sensory organs
responsible for hearing, balance and vision. The inner ear contains the
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el.: +1 801 213 2591; fax: +1respectively (Fig. 1A). In the cochlea, the organ of Corti, themain sound-
sensitive structure, has three rows of outer hair cells (OHCs) and one
row of inner hair cells (IHCs) (Fig. 1B). OHCs receive and amplify
sound-evoked vibrations of the sensory epithelium, whereas IHCs
convert the ampliﬁed mechanical signals into electrical responses [1].
The vestibular system includes the utricle and saccule for detection of
linear acceleration as well as semicircular canal ampullae for detection
of angular acceleration (Fig. 1A) [2,3]. Two types of hair cells, named I
and II, exist in these vestibular sensory organs (Fig. 1C). In both cochlear
and vestibular systems, hair cells are neurons possessing a specialized
mechanosensitive structure, the hair bundle, on their cellular apices
(Fig. 1D). Each hair bundle consists of well-organized, actin-based
stereocilia graded in lengths and a long microtubule-based kinocilium,
although the latter is missing in mature mammalian cochlear hair
cells. Responding to sound, movement or gravity, the hair bundle
deﬂects in the excitatory direction toward the longest stereocilia,
which induces the opening of ion channels at the tip of shorter stereocil-
ia. Inﬂux of cations leads to membrane potential changes, thereby
converting the mechanical stimuli into electrical responses (Fig. 1E), a
process referred to as mechanoelectrical transduction (MET) [1,4,5].
In the retina, photoreceptors (Fig. 2A) are light-sensitive neurons
that are highly compartmentalized. Their outer segment, a modiﬁed
sensory cilium, contains many tightly-packed ﬂat membrane disks har-
boring proteins involved in phototransduction (Fig. 2B). This segment
undergoes active and continuous renewalwith their proteins andmem-
branes synthesized in the inner segment and transported to the outer
Fig. 1. Inner ear anatomy and mechanoelectrical transduction (MET). (A) The position and structure of the inner ear. The inner ear is the most inner part of the ear (left). It contains the
cochlea and vestibular system. The vestibular system includes the utricle, saccule and semicircular canal ampullae (right). (B) Top view of the murine organ of Corti shown by scanning
electron microscopy. The organ of Corti has one row of inner hair cells (IHCs) and three rows of outer hair cells (OHCs). (C) Type I (I) and type II (II) hair cells in the murine utricular
extrastriola shown by immunoﬂuorescence. Phalloidin signal (green) indicates actin bundles in stereocilia. βIII tubulin (red) labels calyx afferents of type I hair cells. Scale bar, 5 μm.
(D) A hair bundle shown by scanning electron microscopy. Top, an entire bundle with a staircase pattern of stereociliary organization. Bottom, an ampliﬁed view of the boxed area on
the top showing a tip link. (E)MET occurs when the hair bundle is deﬂected toward the longest stereocilium (excitatory direction, black arrow). Deﬂection of hair bundles in this direction
stretches tip links, which subsequently regulates the gating ofMET channels and leads to hair cell depolarization. Note that this is a simpliﬁedmodel and tip linksmay associate withMET
channels indirectly.
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Addition of new disks proximally is balanced by shedding of old disks
distally. Retinal pigment epithelium (RPE) cells (Fig. 2A) phagocytose
and digest the shed photoreceptor outer segment tips and participate
in visual pigment regeneration. Proximal to photoreceptors are bipolar
cells, horizontal cells, amacrine cells and ganglion cells (Fig. 2A). Electri-
cal impulses, generated from phototransduction in the photoreceptor
outer segment, are transmitted to the above-mentioned downstream
retinal neurons at the photoreceptor ribbon synapse. Müller cells, the
major glial cells in the retina (Fig. 2A), have large and long radial cellular
processes and form adherens junctions with photoreceptors at the
proximal inner segment. Compromised photoreceptors, RPE cells andMüller cells are now thought to be the cellular basis underlying patho-
genesis of retinitis pigmentosa (RP) (reviewed in [6]).
Usher syndrome (USH), an autosomal recessive genetic disease, is
characterized by hearing loss, vision loss and occasional balance
problems. USH, ﬁrst described by the Scottish ophthalmologist, Charles
Usher, is the leading genetic cause of deaf-blindness with a prevalence
in the range of 1–4 per 25,000 people [7–10]. Based on diverse clinical
symptoms observed in patients, USH is classiﬁed into three types. USH
type I (USH1) patients are deﬁned as having congenital severe-to-
profound deafness, vestibular areﬂexia and onset of RPwithin the ﬁrst
decade of life. USH2 patients show congenital moderate-to-severe
hearing loss, normal vestibular function and onset of RP within the
Fig. 2. Schematic diagrams of the retina and photoreceptor. (A) Cellular organization of the retina. Retinal neurons are arranged into different layers. Photoreceptors and RPE cells are
located in the outer retina, while horizontal cells, bipolar cells, amacrine cells and ganglion cells are downstream neurons of photoreceptors in the inner retina. Müller cells are glial
cells spanning all cell layers of the retina. (B) Photoreceptor structure exempliﬁed by a rod. Photoreceptors are ciliated cells with several specialized subcellular compartments, consisting
of an outer segment having tightly packed membrane disks, a connecting cilium with microtubules, calyceal processes with actin bundles (not shown), an inner segment having all
organelles for energy and protein synthesis, a cell body containing the nucleus, and a synaptic terminus for signal transmission to bipolar and horizontal cells. (C) Magniﬁed drawings
of calyceal processes (top) and periciliary membrane complex (bottom) around the photoreceptor connecting cilium. In order to show the periciliary membrane complex, calyceal
processes are omitted in the bottom drawing.
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dysfunction and onset of RP are progressive, sporadic and variable,
respectively. Early symptoms of RP are night blindness and loss of
peripheral vision, caused by degeneration of rod photoreceptors. Upon
progression of RP, cone photoreceptors also degenerate [8]. Loss of
central (cone-mediated) vision results in USH patients becoming legally
or completely blind with no known cure [11,12].
Signiﬁcant progress has been made recently toward the identiﬁca-
tion of USH causative genes. Through extensive study of these genes
in various animal models, evidence suggests that defects in inner ear
hair cell development and photoreceptor maintenance probably under-
lie USH pathogenesis. In this review, we will summarize the current
knowledge of USH causative genes, disease mechanisms and potential
treatments. We will focus on new discoveries regarding USH etiology,Table 1
USH loci and genes with predicted protein function.
USH type Locus gene name Protein nam
USH1 USH1B MYO7A myosin VIIa
USH1C USH1C harmonin
USH1D CDH23 cadherin 23
USH1E n/a n/a
USH1F PCDH15 protocadher
USH1G USH1G SANS
USH1H n/a n/a
USH1J CIB2 CIB2
USH1K n/a n/a
USH2 USH2A USH2A usherin
USH2C GPR98 VLGR1 (aka
USH2D DFNB31 (Whrn in mice) whirlin
USH3 USH3A CLRN1 Clarin-1
n/a n/a PDZD7 PDZD7because several excellent and comprehensive reviews already exist in
the literature [13–22].
2. Genes and loci identiﬁed in USH patients
To date, sixteen loci have been associated with USH: nine are in-
volved in USH1, three in USH2, two in USH3 and two not speciﬁed
(Table 1) [9,23–27]. From these loci, thirteen genes have been identi-
ﬁed. They include six USH1, three USH2, two USH3, one USH modiﬁer
and one atypical USH genes. The USH1 genes are MYO7A (myosin
VIIa) [28], USH1C (harmonin) [29,30], CDH23 (cadherin 23) [31,32],
PCDH15 (protocadherin 15) [33,34],USH1G (SANS, scaffold protein con-
taining ankyrin repeats and sam domain) [35] and CIB2 (calcium- and
integrin-binding protein 2) [36]. The USH2 genes are USH2A (usherin)e Predicted function References
Actin-based motor protein [28]
PDZ scaffold protein [29,30]
Cell adhesion [31,32]
Unknown [212]
in 15 Cell adhesion [33,34]
Scaffold protein [35]
Unknown [213]
Ca2+ and integrin binding [36]
Unknown [214]
Cell adhesion [37]
GPR98, MASS1) G-protein coupled receptor [38]
PDZ scaffold protein [39]
Auxiliary subunit of ion channels? [40–42]
PDZ scaffold protein [26]
Table 2
Different diseases caused by USH gene mutations.
Gene name USH subtype Other diseases involved References
Myo7a USH1B DFNB2, DFNA11, atypical USH [47–51]
USH1C USH1C DFNB18 [52,53]
CDH23 USH1D DFNB12 [32,54,55]
PCDH15 USH1F DFNB23 [56,57]
CIB2 USH1J DFNB48 [36]
USH2A USH2A Nonsyndromic RP [37,59]
GPR98 USH2C Febrile and afebrile seizures [38,60]
DFNB31 USH2D DFNB31 [39,58]
PDZD7 Digenic USH DFNB [26,215]
DFNB: nonsyndromic recessive deafness.
DFNA: nonsyndromic dominant deafness.
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mal recessive deafness 31) [39]. CLRN1 (Clarin-1) and HARS (histidyl-
tRNA synthetase) are the USH3 genes [25,40–42]. Furthermore, PDZD7
(PDZ domain containing 7)was recently discovered as an USHmodiﬁer
and digenic USH contributor gene [26], and CEP250 as an atypical USH
gene [27]. Among these genes, HARS is debatable as an USH3 gene,
because patients carrying mutations in this gene develop episodic
psychosis as well as progressive hearing loss and RP [25], which could
be clinical symptomsof other rare syndromes. The atypical USHpatients
carrying the homozygous CEP250 nonsense mutation exhibit early-
onset hearing loss and mild RP. They all have a heterozygous C2orf71
nonsense mutation. Although C2orf71is an autosomal recessive RP
gene [43–46], it is unclear whether its heterozygous mutation also
contributes to the disease development of these atypical USH patients.
In addition to involvement in USH, different mutations in nine USH
genes have been reported to cause other discrete diseases (Table 2).
For example, differentmutations inMYO7A are the causes of USH1, non-
syndromic recessive deafness 2 (DFNB2), nonsyndromic dominant
deafness 11 (DFNA11) and atypical USH [47–51]. Other examples
include mutations in USH1C, CDH23, PCDH15, CIB2 and DFNB31, which
lead to either USH or nonsyndromic recessive deafness (DFNB) [32,36,
39,52–58], mutations in USH2A which have been found in patients
with either USH2 or nonsyndromic RP [37,59] and mutations in GPR98
which are responsible for either USH2 or seizures [38,60]. For at least
four USH1 genes,MYO7A, CDH23, PCDH15 and USH1C, there appears toTable 3
USH protein distributions in hair cells and photoreceptors.
Protein name Subcellular distribution
Hair cells
Myosin VIIa Cytoplasm and stereocilia
Harmonin UTLDa and synapse
Cadherin 23 Transient lateral link, kinociliary link, tip link a
Protocadherin 15 Transient lateral link, kinociliary link, tip link a
SANS UTLDa and stereociliary tip
CIB2 stereocilia
Usherin Ankle link and synapse
VLGR1 Ankle link and synapse
Whirlin Ankle link, stereociliary tip and synapse
Clarin-1 hair bundle, apical cytoplasm and synapse
PDZD7 Ankle link
Photoreceptors
Myosin VIIa Connecting cilium, periciliary membrane, calyc
Harmonin Outer segment, calyceal process and synapse
Cadherin 23 Inner segment, calyceal process and synapse
Protocadherin 15 Base of outer segment, calyceal process and sy
SANS Connecting cilium, basal body, calyceal process
CIB2 Inner and outer segment
Usherin Periciliary membrane complex and synapse
VLGR1 Periciliary membrane complex and synapse
Whirlin Periciliary membrane complex
Clarin-1 Connecting cilium, inner segment, adherens ju
PDZD7 unclear
a UTLD: upper tip link density.be a genotype–phenotype correlation in patients [50,54]. Nonsense,
frameshift and splice sitemutations resulting in truncation of USH1pro-
teins are usually responsible for the occurrence of USH1, while ‘leaky’
splice site and somemissensemutations lead only to DFNB. It is hypoth-
esized that mutant alleles causing DFNB and USH1 are hypomorphic
and functionally null alleles, respectively, and that residual function of
USH1proteins from theDFNB alleles spare normal retinal and vestibular
functions in patients [50,54,61]. Additionally, most USH genes have
multiple splice isoforms with different spatial and temporal expression
patterns in the inner ear and retina [29,62–68]. These USH splice iso-
forms could have slightly different cellular functions. Thus, the differen-
tial disruption of USH splice isoforms due to mutations in different USH
gene regions may also contribute to the genotype–phenotype correla-
tion found in patients [53].
3. Expression of USH genes
USH genes are expressed in various tissues [69–74]. This section
addresses their protein expressions in the inner ear and retina (Table 3).
3.1. USH proteins are mainly localized to the hair bundle and synapse of
inner ear hair cells.
Various dynamically-changing proteinaceous ﬁlamentous links
(Fig. 3) exist in hair cell bundles, where USH proteins are localized.
These interstereociliary links are essential for bundle development,
maintenance and function [75–77]. During early development,
kinociliary links connect the kinocilium to its neighboring stereocilia,
and transient lateral links connect adjacent stereocilia along their entire
length [75,76]. Later, ankle links and tip links emerge at the stereociliary
base and tip, respectively [76]. Tip links connect the tip of shorter
stereocilia to the lateral wall of taller stereocilia (Figs. 1D and 3) and
mediate gate opening of ion channels during MET (Fig. 1E). Electron
dense structures, upper (UTLD) and lower (LTLD) tip link densities
(Fig. 3), are observed at the upper and lower insertion sites of tip links
in stereocilia, respectively. Kinociliary links, transient lateral links and
ankle links disappear after maturation of mammalian cochlear hair
cells, but some are permanent in the vestibular system [75,76]. TipReferences
[86–90]
[84,85,90,99,104]
nd synapse [79–82,90,101,103]
nd synapse [63,79,83,90,102,103]
[86,139]
[36]
[68,77,99,100]
[77,93,99,100,102,103]
[66,68,77,94–96,100]
[97,98]
[68,94]
eal process and synapse [19,20,105,109,112]
[19,99,105,112,113]
[19,105,112]
napse [19,105,112]
and synapse [105,111,133]
[36]
[17,19,68,99,100,105,106,116,117]
[19,68,99,100,105,106,117]
[17,68,100,105,106,111,117]
nction and synapse [97,118]
[26,68]
Fig. 3. Dynamic changes of various interstereociliary links in the hair bundle during and after development. During embryogenesis, emerging stereocilia are bundled by transient lateral
links and connected with the kinocilium through kinociliary links. Postnatally, the transient lateral links are gradually replaced by tip links, apical lateral links and ankle links. After mat-
uration, the apical lateral links are replaced by horizontal top connectors. Upper tip link density (UTLD) and lower tip link density (LTLD) are electron-dense structures at the insertion sites
of tip links in the taller and shorter stereocilia, respectively. In mature rodent cochlear hair cells, the ankle links, kinociliary links and kinocilium disappear.
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[78,79].
Among USH1 proteins, cadherin 23 and protocadherin 15 are local-
ized to transient lateral links and kinociliary links during development
and to tip links in adulthood [63,80–83]. Harmonin and SANS are part
of the UTLD [84–86]. CIB2 was found in both hair cells and supporting
cells [36]. In hair cells, CIB2 is localized along stereocilia and more
concentrated near the tip. Myosin VIIa is distributed throughout hair
cells including the cytoplasm and hair bundle [87–89]. This protein
has been shown to be at the tip, base, shaft or entire length of stereocilia
by different research laboratories [86,87,90–92]. These inconsistent
myosin VIIa signal patterns may result from 1) different detection
approaches, such as immunostaining of the endogenous protein or
overexpression of a tagged exogenous protein; 2) different myosin
VIIa antibodies, which could have variable quality and/or detect differ-
entmyosin VIIa isoforms; 3) different hair cell types, such as the cochle-
ar IHCs, OHCs or vestibular hair cells, examined at different developing
time points; and 4) various sample processing procedures.
The protein of the USH2 gene GPR98, VLGR1 (very large G protein-
coupled receptor 1), has been shown to be a major component
of ankle links [77,93]. Other USH2 proteins usherin and whirlin
(DFNB31), together with PDZD7, are colocalized with VLGR1 at the
ankle link complex [68,77,93,94]. Additionally, whirlin is also present
at the stereociliary tip [66,95,96]. Among USH3 proteins, clarin-1 is
relatively well studied in the inner ear. While clarin-1 could not be
found in the hair bundle of zebraﬁsh mechanosensory hair cells [97],
its presence in mouse cochlear hair bundles was suggested [98].
USH proteins are also found in the synapse of hair cells, where
the electrical responses generated from MET are transmitted to
second-order neurons in the inner ear. Protocadherin 15, cadherin 23,
harmonin, clarin-1, usherin, VLGR1 and whirlin have all been reported
in the synapses of developing and mature hair cells [97,99–104].
3.2. USH proteins are localized in photoreceptors and other retinal
cell types.
Cellular distributions of USH proteins in the retina are less well-
deﬁned, owing to inconsistent reports in the literature. These inconsis-
tent reports might result from different antibodies, different sample
processing procedures and/or different species used in the studies. In
general, USH proteins have been localized in photoreceptors and some
other retinal cells, andmay have distinct distribution patterns in retinas
of different species. In photoreceptors, they tend to be positioned to
some speciﬁc subcellular structures (Table 3).
One such structure is the calyceal process of long actin-based,
microvilli-like thin projection (Fig. 2C). Calyceal processes extend
from the inner segment apex toward the outer segment, and wrap
tightly around the basolateral outer segment. Calyceal processes existin primate, amphibian and avian photoreceptors, but are absent and
vestigial in rodent rods and cones, respectively [105]. Although differing
in function, calyceal processes and the outer segment of photoreceptors
are considered structurally similar to stereocilia and the kinocilium of
hair cells. Another structure related to USH proteins is the periciliary
membrane complex in mammalian photoreceptors (Fig. 2C), which is
a specialized plasmamembrane region at the inner segment apex facing
the connecting cilium. The periciliary membrane complex is thought
to be analogous to the periciliary ridge complex [106], which likely
participates in protein trafﬁcking between frog photoreceptor inner
and outer segments [107].
In mice, USH1 protein myosin VIIa exists mostly in RPE cells [89,
108]. Its localization in photoreceptors at the connecting cilium and
periciliary membrane remains open to debate [20,109,110]. Other
USH1 proteins were localized to various photoreceptor compartments,
including the outer segment, connecting cilium, inner segment and syn-
apse [36,56,99,111–113]. Some of theseﬁndings are inconsistent among
different research groups [99,105,113]. Apart from photoreceptors, CIB2
was found in RPE and other retinal cells [36]. Recently, Sahly et al. re-
ported that USH1 proteins, except CIB2 (not examined), are all located
at calyceal processes of human, monkey and frog photoreceptors [105]
. The USH1 protein localization in photoreceptor calyceal processes, to
some extent, corresponds with their localization in hair cell stereocilia.
Additionally, studies in zebraﬁsh illustrate that cadherin 23 and
harmonin are localized in a small subset of GABAergic amacrine cells
and Müller cells, respectively [114,115]. In summary, USH1 proteins
may have variable cellular and subcellular distributions in retinas of
different species.
USH2 proteins usherin, VLGR1 and whirlin were initially positioned
in the inner segment, connecting cilium, basal bodies, synaptic terminus
and adherens junction of mouse photoreceptors [17,19,100,111]. Using
antibodies whose speciﬁcities have been veriﬁed stringently, the three
USH2 proteins are now localized to the periciliary membrane/ridge
complex ofmouse and frog photoreceptors [106,116,117]. USH2protein
localizations at the periciliary membrane complex were further con-
ﬁrmed in monkey photoreceptors [105].
Distribution of USH3 protein clarin-1 in the retina has been reported
by three research groups and remains inconclusive [97,118,119]. In
mouse retinas, one group showed that clarin-1 protein is present in
the photoreceptor connecting cilium, inner segment and synaptic ter-
minus [118], whereas others demonstrated that clarin-1 mRNA exists
only during development in Müller cells but not photoreceptors [119].
In zebraﬁsh retinas, Phillips et al. found that the clarin-1 protein is dis-
tributed in photoreceptors and other retinal cells, which could be
amacrine cells, Müller cells and ganglion cells, during development
and adulthood; in photoreceptors, clarin-1 is localized to the inner
segment lateral membrane, adherens junctions with Müller cells and
synaptic terminus [97].
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Individual USH proteins are predicted to accomplish various
functions including actin-based intracellular trafﬁcking, cell adhesion,
scaffolds inmultiprotein complexes, and G protein- or Ca2+-mediated
signaling (Table 1). For example, myosin VIIa is revealed as an uncon-
ventional motor protein with a motor domain, actin-binding domain
and long tail region [120,121]. Harmonin, whirlin and PDZD7 are
paralogs belonging to the same protein family. These three proteins
and SANS each have several protein–protein interaction domains
and thus are thought to be scaffold proteins [18,68,99,106,117,122,
123]. Cadherin 23, protocadherin 15 and usherin are transmembrane
proteins with a long extracellular region containing various cell
adhesion domains, suggesting a potential function of binding cell sur-
face proteins and/or extracellular matrix proteins [79,83,124]. CIB2
has several Ca2+-binding EF-hand domains and is able to bind to
integrin [36], while VLGR1 is a very large adhesion G protein-
coupled receptor with multiple extracellular Ca2+-binding motifs
[70]. Recent colocalization, in vitro interaction and mouse genetic
studies on USH proteins suggest that proteins within the same USH
clinical type interact to form multiprotein complexes (Fig. 4) and
that mutations in USH genes lead to protein complex disruption and
disease development [18,77,90,106]. Therefore, the distinct functions
of individual USH proteins probably contribute to the function of
USHmultiprotein complexes as a whole in various subcellular regions
of hair cells and photoreceptors [17–19,21,22,125]. Here, we present
one USH1 complex and one USH2 complex to exemplify USH
multiprotein complexes.
USH1 proteins harmonin, SANS and myosin VIIa are suggested to
form a complex (Fig. 4) at theUTLD inmature inner ear hair cells by sev-
eral lines of evidence. Genetic and cell biological studies have revealed
interdependence of these proteins for their normal localizations at the
UTLD in mice [84,86]. Structural and biochemical studies further showFig. 4. Known interaction networks among USH proteins. (A) Interactions among USH1 (pink)
assays. Interactions among the two USH3 (blue), atypical USH (CEP250) and other USH prot
hair cells (left) and photoreceptors (right) by genetic studies. Reference numbers are given alothat harmonin and SANS, the two scaffold proteins, form a complex
through the harmonin PDZ1 domain and SANS SAM region and PDZ-
binding motif (PBM) [123]. The harmonin N-domain in the harmonin/
SANS complex is open and available to interact with the cadherin 23
short cytoplasmic region [91,126,127], and the CEN domain of SANS is
able to bind to the FERM and MyTH4 domains of myosin VIIa [122,
128]. Thus, the USH1 complex of harmonin, SANS and myosin VIIa is
thought to anchor the cadherin 23 component of tip links to actin
ﬁlaments inside taller stereocilia [84]. Latest studies in zebraﬁsh hair
cells also found that cadherin 23, myosin VIIa and harmonin are likely
preassembled into a complex at the endoplasmic reticulum (ER),
where the proteins are synthesized [129]. Defects in any of the three
proteins affect trafﬁcking of the complex to hair bundles and induce
ER stress and apoptosis in hair cells [129].
USH2 proteins usherin, VLGR1 and whirlin are able to interact
in vitro through PDZ domains of whirlin and PBMs of usherin and
VLGR1 (Fig. 4) [65,100,106]. They are colocalized at the photoreceptor
periciliary membrane complex (Fig. 2C) [105,106,111,116,117] and
the developing hair cell ankle link complex (Fig. 3) [65,77,93]. Loss of
one USH2 protein affects the normal localizations of other USH2 pro-
teins in photoreceptors [106] and hair cells ([77] and our unpublished
data), and whirlin is able to recruit usherin and VLGR1 to the photore-
ceptor periciliary membrane complex [117]. These ﬁndings indicate
that USH2 proteins exist as a multiprotein complex in vivo. USH modi-
ﬁer protein PDZD7 also interacts directly with the three USH2 proteins
(Fig. 4) [26,68] and colocalizes with VLGR1 and whirlin at the hair cell
ankle link complex [68,94]. PDZD7 and the three USH2 proteins aremu-
tually dependent for normal localizations in cochlear hair cells [68,77].
However, localization of PDZD7 at the photoreceptor periciliary mem-
brane complex could not be determined [26,68]. Ablation of PDZD7
did not affect the integrity of the USH2 complex in mouse photorecep-
tors [68]. Therefore, PDZD7 is probably a component of the USH2
multiprotein complex in hair cells but not photoreceptors. Currently,, USH2 (green) and PDZD7 proteins found and conﬁrmed by various in vitro biochemical
eins have not yet been revealed. (B) Interactions of USH proteins conﬁrmed in inner ear
ng each line.
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Linkage between USH1 and USH2 multiprotein complexes appears
likely (Fig. 4). For instance, USH1 protein CIB2 was shown to be capable
of binding to both USH1 protein myosin VIIa and USH2 protein whirlin
in vitro [36]. Another in vitro biochemical study demonstrated mole-
cular interactions between USH1 scaffold protein harmonin and
USH2 proteins usherin and VLGR1 [99]. Therefore, USH proteins are
currently thought to function cooperatively in vivo through the
intertwined network of their multiprotein complexes. However, it is
still elusive as to how these multiprotein complexes coordinate func-
tionally at their distinct subcellular locations, although association
among USH multiprotein complexes could occur transiently during
trafﬁcking from the ER to ﬁnal destinations.
To thoroughly understand the biological functions of various USH
multiprotein complexes, extensive efforts have been implemented to
identify novel partners that interact with known USH proteins, mainly
through yeast two-hybrid screen, in vitro biochemical conﬁrmation
and in vivo immunolocalization. Espin 1–3 isoforms, derived from
alternative usage of transcriptional start sites and alternative splicing,
were discovered to associate with the USH2 protein complex [74].
Espins bind to actin monomers and bundle actin ﬁlaments [130]. They
colocalize partially with whirlin at the photoreceptor periciliary mem-
brane and hair cell ankle link complexes. Interaction between espins
and whirlin in vivo appears important for the maintenance of actin
bundle geometry [74]. Other recent ﬁndings describe interactions of
myomegalin with the SANS CEN domain [131], SPAG5 (sperm-associat-
ed antigen 5, also called astrin) with the usherin cytoplasmic region
[132], and Magi2 (membrane-associated guanylate kinase inverted-2)
with the SANS SAM region [133]. However, caution is needed when
data from screens of USH protein-interacting partners are interpreted
physiologically, because some of the interactions have not been con-
ﬁrmed in vivo [134,135].5. Functional studies of USH gene products
5.1. USH genes in inner ear hair cells
5.1.1. USH1 genes
Mice and zebraﬁsh carrying mutations in USH1 gene orthologs, ex-
cept CIB2 (not reported yet), share commonmorphological phenotypes
of their hair bundles [81,90,115,136,137]. Cdh23v2J/v2J, Pcdh15av3J/av3J,
Ush1gjs/js, Myo7a4626SB/4626SB and Ush1c−/−mice have fragmented hair
bundles with planar cell polarity defects in both IHCs and OHCs [90],
which are similar to the hair bundle phenotypes found in myo7a,
cdh23, pcdh15 and ush1cmutant zebraﬁsh [81,115,136,137]. Such mor-
phological defects caused by USH1 gene mutations could result from
disconnection between the kinocilium and neighboring stereocilia,
and among stereocilia themselves. Therefore, proteins encoded by
USH1 genes probably function cooperatively in maintaining cohesionTable 4
MET defects in USH1 mutant mice.
Mouse MET defects
Cdh23v2J/v2J Reduced current and abnormal direc
Pcdh15av3J/av3J Reduced or no current and abnorma
Pcdh15av6J/av6J Reduced current and abnormal direc
Myo7a6J/6J Increased current, decreased sensitiv
Myo7a4626SB/4626SB Increased current, decreased sensitiv
Ush1cdfcr/dfcr Decreased sensitivity of OHCsa
Ush1cdfcr-2J/dfcr-2J Reduced OHC current and abnormal
USH1gﬂ/ﬂ;Myo15-Cre+/− Reduced current and normal sensitiv
a The discrepancy of MET defects found in USH1mice carrying differentmutant alleles of the
for MET measurements, such as either ﬂuid jet or stiff glass probe stimulation.of stereocilia and kinocilium in developing and mature hair bundles as
components of tip links, UTLD and other interstereociliary links.
Stereociliary tip links are absent in Cdh23v2J/v2J, Pcdh15av3J/av3J and
Ush1g−/−mice [138,139] and in cdh23tc317e/tc317e, cdh23tc300a/tc300a and
cdh23tc370e/tc370e zebraﬁsh [81]. Consistently, various MET abnormalities
have been reported in Cdh23, Pcdh15,Myo7a, Ush1c and Ush1gmutant
mice (Table 4), which were recorded in vitro by either ﬂuid jet
or stiff glass probe stimulation. Among these USH1 mutant mice,
Ush1gﬂ/ﬂMyo15-cre+/− mice have intact hair bundle morphology.
Thus, abnormal MET responses detected in USH1 mutant mice are
probably primary and not secondary to bundle morphological defects.
Knockdown of cib2 in zebraﬁsh causes reduced microphonic potentials
of neuromasts, suggesting that CIB2, like other USH1 proteins, is also
essential for MET responses in hair cells [36]. Therefore, USH1 proteins
are either directly or indirectly involved in the MET process in the hair
cell bundle.
Harmonin has also been found in synaptic termini of mouse, rat and
zebraﬁsh hair cells [99,104,115]. In mature cochlear IHC synapses,
harmonin interacts with the cytoplasmic terminus of Cav1.3α1 subunit,
the pore-forming subunit of voltage-gated Cav1.3 Ca2+ channels, which
is essential for Ca2+-dependent glutamate release and synaptic trans-
mission. Harmonin controls the amount of Cav1.3 α1 on the synaptic
plasma membrane by increasing ubiquitination of Cav1.3 α1 subunit,
improves voltage-dependent facilitation of Cav1.3 Ca2+ channels, and
regulates exocytosis of vesicles containing readily releasable neuro-
transmitters at synaptic ribbons [104,140].
5.1.2. USH2 genes
Most mouse models carrying USH2 gene mutations share common
phenotypes. In Gpr98−/− and Gpr98del7TM/del7TM mice, ankle links
are completely missing, indicating that VLGR1 is a core protein of
ankle links [77,93]. In all reported Gpr98, Ush2a,Whrn (mouse ortholog
of DFNB31) and Pdzd7 mutant mice, except Whrnwi/wi mice [58,141],
abnormal stereociliary organization was observed in OHC but not
IHC bundles [68,77,93,106,116,142,143]. Consistently, Gpr98−/−,
Gpr98del7TM/del7TM and Pdzd7−/− mice have reduced MET amplitude
and sensitivity in OHCs, but normal MET responses in IHCs [68,77,93].
USH2mutantmice, exceptWhrnwi/wimice, exhibit no obvious behaviors
of vestibular dysfunction. Gpr98−/−, Gpr98del7TM/del7TM and Pdzd7−/−
vestibular hair cells also have normal MET responses [68,77,93]. These
ﬁndings indicate that USH2 proteins at the ankle link complex are im-
portant for organizing stereocilia into a V-shaped bundle during OHC
development and raise a possibility that neither USH2 proteins nor
the ankle link complex may function signiﬁcantly in IHCs or vestibular
hair cells.
By contrast,Whrnwi/wimice show shortened stereocilia in both IHCs
and OHCs as well as disorganized OHC bundles [58,141,144]. The mice
have circling and head tossing phenotypes, indicative of vestibular dys-
function. It is currently hypothesized that the more severe phenotypes
found in Whrnwi/wi mice are probably due to the combined defective
Whrn expressions at both the tip and ankle link complex of stereociliaReferences
tional sensitivity [138]
l directional sensitivitya [92,138]
tional sensitivitya [138]
ity and abnormal adaptation [216]
ity and abnormal adaptation [216]
[84]
adaptation of outer and vestibular hair cellsa [85]
ity [139]
same gene could result from differences in splice isoforms affected and/or conditions used
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be normal [145].
5.1.3. USH3 genes
Similar tomost USH2mutantmice, Clrn1−/−mice showmorpholog-
ical defects of OHC but not IHC bundles [146], and they have reduced
MET amplitude and sensitivity in OHCs but normal MET responses in
IHCs [98] during development. However, unlike most USH2 mutant
mice, Clrn1−/− mice exhibit progressive vestibular dysfunction with
no overt circling or head tossing behaviors by one month of age but
severe circling and head tossing behaviors by 6months of age [146]. Ad-
ditionally,MET responses in Clrn1−/− vestibular hair cells show reduced
currents and less sensitivity [98]. Consequently, USH2 and USH3
proteins might participate in similar cellular processes of stereocilia
organization in the cochlea, but play relatively distinct roles in the
vestibular system during bundle development.
5.1.4. In summary
Proteins encoded by most USH genes, as various interstereociliary
links, confer cohesive organization of stereocilia during bundle growth
and differentiation. Some USH proteins remain functional in adult hair
cells at important subcellular structures, e.g., tip links and tip link densi-
ties. The bundle morphological defects caused by USH gene mutations
may affect establishment of the MET process, which is likely causal for
hearing loss and, sometimes, vestibular areﬂexia. Thus, USH proteins
are required for development, maintenance and function of inner ear
hair cell bundles. Some USH proteins may additionally serve a synaptic
transmission role from hair cells to downstream neurons.
5.2. USH genes in the retina
Current understanding of USH genes affecting retina health is frag-
mentary. The only relatively well-understood USH gene in the retina
isMYO7A. Myosin VIIa in RPE cells is implicated in drivingmelanosomes
into apical processes [147], delivering phagosomes to their cytoplasmic
digestion site from apical processes [148], and translocating RPE65, an
enzyme important for visual pigment regeneration [149]. In photore-
ceptors, delay of rhodopsin transport to the outer segment is shown in
three different strains of Myo7a mutant mice and myo7aaty229d/ty229d
zebraﬁsh (Zebraﬁsh has two human MYO7A orthologs, myo7aa and
myo7ab.) [150,151]. The role of myosin VIIa in rhodopsin transport is
proposed to be achieved through direct interaction of myosin VIIa
with spectrin-βV, an adaptor protein associating with rhodopsin,
kinesin-II and the dynein complex [152]. Further, Myo7ash1-11J/sh1-11J
mice have a delay and increased threshold of transducin translocation
from the outer to inner segment upon light stimulation [153]. Together,
these ﬁndings suggest that myosin VIIa is important for protein and
organelle transport in both RPE cells and photoreceptors of the retina.
Physiological and histological studies in various Myo7a mutant
mouse and myo7aa mutant zebraﬁsh retinas produced somewhat in-
consistent results, possibly resulting from different mutant species and
strains, genetic backgrounds, retinal pigmentation levels and light illu-
mination levels used in the experiments [149,151,153–155]. Electroret-
inogram (ERG) recording is a non-invasive technique tomeasure retinal
electrical responses to light stimuli with resulting a- and b-waves
representing responses from photoreceptors and inner retinal neurons,
respectively. Myo7a4626SB/4626SB, Myo7a816SB/816SB, Myo7a7J/7J,Myo7a8J/8J
and Myo7a9J/9J mice and myo7aaty229d/ty229d mutant zebraﬁsh exhibit
reduced ERG a- and b-wave amplitudes but normal light sensitivity
[151,155], while albino Myo7a4626SB/4626SB mice show an age-
dependent reduction of ERG b-wave, less light sensitivity and slow re-
covery from light desensitization [154]. Inmyo7aaty229d/ty229d zebraﬁsh,
mild retinal degeneration, indicated by photoreceptor loss, was ob-
served at 10 days postfertilization [151], while no retinal degeneration
occurs in all Myo7a mutant mice examined under normal husbandry
conditions. Light illumination can induce retinal degeneration inMyo7ash1-11J/sh1-11J [153] but notMyo7a4626SB/4626SBmice [149]. Although
inconsistently observed by different research groups, most physiologi-
cal and histological abnormalities can be rescued by delivery ofMyo7a
cDNAs into RPE and photoreceptor cells of Myo7a mutant mice using
either adeno-associated virus (AAV) or lentivirus [154,156–159],
suggesting that the above identiﬁed phenotypes are speciﬁc toMyo7a
mutations.
The second well-studied USH genes in the retina are the group of
USH2 genes. In Ush2a−/−, Gpr98del7TM/del7TM and Whrnneo/neo mice, the
integrity of the USH2 complex is disrupted at the photoreceptor
periciliary membrane complex [106]. Ush2a−/− and Whrnneo/neo mice
exhibit late-onset weak retinal degeneration [106,116]. Consistently,
knockdown of ush2a and gpr98 in zebraﬁsh results in an increase of
dying photoreceptors [26]. Therefore, the USH2 complex is important
for photoreceptor survival. However, the exact biological function of
the USH2 complex in photoreceptors remains elusive. Originally, the
USH2 complex at the periciliary membrane complex was proposed to
participate in protein trafﬁcking through the connecting cilium [107],
but no clear evidence demonstrates any defects in protein trafﬁcking
between the inner and outer segment in Ush2a−/− and Whrnneo/neo
photoreceptors [106,116]. Interestingly, using Whrnwi/wi mice, which
do not develop spontaneous retinal degeneration [106], Tian et al.
demonstrated a defect in light-induced transducin translocation from
photoreceptor outer to inner segment and light-induced retinal degen-
eration [160]. Themolecular mechanisms underlying these phenotypes
inWhrnwi/wi mice need to be further elucidated.
Among all reported USH1 and USH3 mouse models, the Ush1c
knock-in mouse is the only one to have a spontaneous retinal degener-
ation phenotype [161],mimicking the RP symptoms of USH1patients. In
this knock-in mouse, a c.216GNA cryptic splice site mutation in USH1C,
cloned from Acadian USH1 patients in Louisiana, was inserted into the
mouse genome to replace the normal mouse Ush1c sequence [162]. It
has been proposed that gain-of-function or dominant-negative effect
of a truncated harmonin protein fragment from aberrant splicing
account for the degeneration. Additionally, ush1cfh293/fh293 zebraﬁsh
line was recently found to have progressive retinal degeneration
through labeling of apoptotic marker caspase-3 [115]. Despite these
ﬁndings, the function of harmonin in the retina remains unidentiﬁed.
In summary, little is known of USH protein function in the retina,
except myosin VIIa. One of the reasons is that mouse models with mu-
tant USH genes typically have no or weak retinal phenotypes and thus
provide limited insight.
5.3. USH genes in other tissues
Three patients from two unrelated Arabic consanguineous families
were found to have profound congenital deafness and enteropathy
caused by a deletion in the USH1C gene [30], suggesting that USH1C
may have a function in the intestine in addition to the inner ear and ret-
ina. Harmonin was recently localized at the tip of intestinal epithelial
cell microvilli, which are structurally analogous to hair cell stereocilia
[69]. At this place, harmonin is able to anchor protocadherin 24,
mucin-like protocadherin and myosin VIIb through direct interactions.
In Ush1c−/−mice, altered morphology and complete disappearance of
microvilli were found in 10–40% of epithelial cells of the small intestine
and proximal colon, suggesting an important role of harmonin in main-
taining the structure of intestinal enterocytes. Even so, the intestinal
physiology ofUsh1c−/−mice appears normal [69], indicating a potential
high tolerance of the intestine to loss of harmonin, which may explain
the absence of enteropathy in most patients carrying USH1Cmutations.
Whirlin protein has been localized in various neurons in the rat cere-
brum, cerebellum and thalamus [73] in addition to hair cells and photo-
receptors. This protein is required for maintenance of paranodal
organization and prevention of subcellular organelle accumulation in
myelinated axons of the central and peripheral nervous systems [163].
Another study involving a large-scale phenotyping screen unexpectedly
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mutant mice [164]. Female Whrntm1a(EUCOMM)Wtsi mutant mice at 10
weeks of age and fed on a high fat diet were able to stay on a 52 °C
hot plate longer than controls, indicating that whirlin may be involved
in thermal pain perception. In Drosophila, the closest homolog of
DFNB31, dysc (dyschronic),was recently identiﬁed as a novel component
of the circadian output pathway [165]. DYSC protein is present in the
major neuronal tracks throughout theﬂy central brain. It probably func-
tions through forming a complex with a calcium-activated potassium
channel SLOWPOKE and regulating the expression of this channel.
Several dysc mutants generated by the P-element insertions have nor-
mal central circadian machinery, but exhibit an arrhythmic locomotor
behavior. These ﬁndings indicate a potential role ofwhirlin in regulation
of circadian rhythm in the brain. DFNB31 is known to have multiple
alternatively-spliced isoforms, whirlin long and short isoforms [58,
166]. Whirlin long isoforms are predicted to be disrupted in all the mu-
tant mice and ﬂies used in the above studies. Therefore, the potential
whirlin functions in the brain are probably attributed to whirlin long
isoforms.
USH2Awas shown to be associatedwith touch sensitivity and acuity.
Studies on two cohorts of USH patients from Germany and Spain have
revealed that the tactile acuity and vibration detection threshold are
compromised in patients carrying pathogenic USH2A mutations, but
not in other USH2 patients [167]. Furthermore, patients with USH2A
mutations in the study were found to have a slightly but signiﬁcantly
lower heat pain threshold. Therefore, the USH2A and DFNB31 genes
seem to be in the same neuronal sensory pathway as in vision and
hearing, although the effects of the twogenes on theheat pain threshold
appear opposite. However, due to the small sample sizes in the two
studies [164,167], involvement of the DFNB31 and USH2A genes in the
thermal pain perception needs to be further veriﬁed, and the underlying
mechanisms need to be elucidated.
Before its discovery as the USH2C gene [38], GPR98 and its ortholog
were originally identiﬁed as a causative gene for febrile and afebrile
seizures in humans [60] and for audiogenic epilepsy in mice [168].
GPR98 ortholog mRNAs were detected in the mouse and zebraﬁsh
brains [67,169]. VLGR1 protein is highly enriched in the mouse mid-
brain superior and inferior colliculi [70], while inferior colliculus is
known to participate in the occurrence of audiogenic seizures [170]. In
oligodendrocytes of the mouse superior and inferior colliculi, VLGR1
regulates the stability of myelin-associated glycoprotein [70], a protein
functioning in the axon–glial interaction at the periaxonal membrane
of glial myelin sheaths [171]. As mentioned, whirlin is involved in the
paranodal organization between the glial myelin sheaths and their
wrapped axons [163]. Therefore, both VLGR1 and whirlin likely play a
role in nerve axon myelination in the brain.
6. Insights from current literatures about USH genes in
various tissues
USH proteins are generally localized to folded plasma membrane
structures. For example, USH1 proteins are present at inner ear hair
cell stereocilia (Fig. 3) [36,79,80,82–86,90,139], retinal photoreceptor
calyceal processes (Fig. 2C) [105] and intestinal enterocyte microvilli
[69]. USH2 proteins are present at the ankle link complex of the hair
cell stereociliary base (Fig. 3) [68,77,93,94] and the periciliary mem-
brane complex of the photoreceptor inner segment apex facing the
connecting cilium (Fig. 2C) [68,105,106,116]. In the nervous system,
although the exact cellular or subcellular localizations of whirlin and
VLGR1 in myelinated nerves are unclear [70,163], it is possible that
these two proteins are present in themyelin sheath, layers of the folded
plasma membrane of oligodendrocytes or Schwann cells, to fulﬁll their
functions. The folded plasmamembrane structures,where USHproteins
are localized, are likely highly dynamic. For example, the plasma mem-
brane of hair cell stereocilia probably moves toward the tip when
stereocilia grow rapidly during development; the plasma membraneof the photoreceptor connecting cilium and outer segment probably
moves distally during outer segment renewal. Considering the cell ad-
hesion, Ca2+-binding and cell signaling domains predicted in several
USH proteins and the localizations of most USH proteins on or near
the plasmamembrane, USH proteins maymediate signaling to regulate
and maintain the dynamic organization of folded membranous
structures.
USH proteins are believed to be assembled in multiprotein
complexes with other USH and non-USH proteins. As scaffold proteins,
harmonin, SANS, whirlin and PDZD7 are essential for organization of
these multiprotein complexes. These scaffold proteins bind to their
partners mostly through PDZ domains and PBMs with weak afﬁnities
in the micromolar range [172]. Therefore, interactions in USH
multiprotein complexes are probably transient, consistent with the
signaling and dynamic cell adhesion roles of these complexes. PDZ
domain-mediated interactions are promiscuous [172]. Their speciﬁcity
is usually regulated in spatial, temporal and cell type-speciﬁc manners.
This may explain that the composition and organization of USH
multiprotein complexes vary according to tissue. Compared with the
harmonin-containing USH1 protein complex at the UTLD in hair cells
[91,122,123,126–129], harmonin forms a complex with completely
different proteins, protocadherin 24, mucin-like protocadherin and
myosin VIIb, at the tip of microvilli in enterocytes [69]. Likewise,
PDZD7 plays a crucial role in the USH2 protein complex formation in
hair cells, but is dispensable for the complex formation in photorecep-
tors [68]. Despite the USH multiprotein complex variation in different
tissues, individual USH proteins probably conduct similar functions
among different complexes. VLGR1 protein was shown to sense the ex-
tracellular calcium changes and activate PKA and PKC through binding
to Gαs and Gαq, respectively, in the superior and inferior colliculi [70]
. This protein was also demonstrated to couple Gαi signaling in over-
expressed cell cultures [173]. These signaling pathways could therefore
co-exist at the VLGR1-containing USH2 protein complex in both hair
cells and photoreceptors. Further, myosin VIIa transports cellular organ-
elles and proteins in RPE cells and photoreceptors [147–151]. Thus, this
protein could also participate in intracellular transport in hair cell
stereocilia and cytoplasm, although myosin VIIa is generally proposed
to anchor USH proteins to actin bundles in hair cell stereocilia. Based
on dissimilarities of USH multiprotein complexes in various tissues
and potential similarities of USH proteins in differentmultiprotein com-
plexes, it is crucial to investigate USH proteins/multiprotein complexes
in all tissues where present.
7. Current progress in therapeutic studies on USH
As mentioned, no cure for USH has been discovered so far. Present
treatments mostly attempt to ameliorate hearing loss or retinal degen-
eration symptomatically. Here we describe therapeutic approaches that
have been investigated with either success or promise.
7.1. Cochlear, vestibular and retinal implants
Cochlear implantation has proven to be a successful therapeutic
approach for USH patients [174–176]. The majority of USH children
receiving cochlear implants at their early age are able to hear open-set
speech and develop oral communication skills at some level. Although
enormous progress has been made in retinal prosthesis, the current
implantation approach is less successful than cochlear implantation in
terms of visual acuity that can be achieved [177]. Development of
vestibular implants is still in its infancy [178,179].
7.2. Application of antisense oligonucleotides (ASO)
Striking progress in rescuing hearing and vestibular function has
been achieved via application of ASOs in the Ush1c knock-in mouse
model [180]. Peritoneal injection of an 18-bp ASO in Ush1c knock-in
415P. Mathur, J. Yang / Biochimica et Biophysica Acta 1852 (2015) 406–420mice at postnatal day 5 was able to restore vestibular function up to 9
months and hearing function up to 6 months, the two longest time
points tested [180]. In this study, 15–18 bp ASOs were designed to
have base sequences complementary to the patient genomic DNA
region containing the USH1C 216GNA mutation. These ASOs were able
to block the cryptic 5′ splice site generated by the mutation, which
leads to production of a small amount of normal harmonin protein.
Investigators are now evaluating the rescue effect of ASOs in the retina.
This technique is currently limited to a speciﬁc class of mutations that
generate cryptic splice sites.
7.3. Gene replacement therapy using viral vectors
Viral-mediated gene replacement therapy has attracted favor due
to its encouraging efﬁcacy and safety results obtained from clinical tri-
als for an early-onset retinal degenerative disease, Leber's congenital
amaurosis, using serotype 2 AAV [181–183]. However, AAVs have a
cargo packing limit of 4.7 kb while the most common causative
USH1 and USH2 genes, MYO7A and USH2A, respectively, are much
larger than this packing limit. Recent studies on the gene replacement
therapy for USH have focusedmainly on ﬁndingways to deliver a large
gene, especially MYO7A, into target retinal cells using various viral
vectors.
Four strategies have been reported using AAVs [154,157–159,184,
185]. One is to pack the entire 7-kb human MYO7A cDNA into single
AAV particles, even though this cDNA is signiﬁcantly larger than
the AAV packing limit [154,157]. These oversized AAV particles are
able to inducemyosin VIIa protein expression in both RPE and photore-
ceptor cells after subretinal injection, rescue the molecular and cellular
defects in these retinal cells, and improve the functional recovery of
Myo7a4626SB/4626SB retinas after light desensitization [154,157]. Howev-
er, oversized single AAV vectors tend to have heterogeneous genomes,
raising safety concerns during clinical application. The other three
strategies entail application of dual AAV overlapping, trans-splicing
and hybrid vectors [157,158,184,185]. In these, N- and C-terminal
halves of MYO7A cDNA, packed into two separate AAV vectors, are
designed to reconnect inside target cells through homologous recombi-
nation (overlapping), trans-splicing, or both (hybrid) [158,185]. It was
found that dual AAV trans-splicing andhybrid vectors have better trans-
duction efﬁciencies for both RPE and photoreceptor cells, compared
with oversized single AAV and dual AAV overlapping vectors [158].
Subretinal injection of dual AAV trans-splicing and hybrid vectors in
Myo7a4626SB/4626SBmicewas shown to lead to robustmyosin VIIa protein
expression in the retina and to rescue the normal localizations of mela-
nosome in RPE cells and rhodopsin in photoreceptors [158].
Lentiviral vectors are able to pack a transgeneup to 7.5 kb long [186].
HIV (human immunodeﬁciency virus)- and EIAV (equine infectious
anemia virus)-based lentiviral vectors are capable of delivering the
MYO7A gene into mouse photoreceptors and RPE cells to provide
‘rescue’ of phenotypes in Myo7amutant mice [156,159]. A phase I/IIa
clinical trial using the EIAV-based lentiviral vector carrying the human
MYO7A gene, UshStat® (Oxford BioMedica), is being conducted by
Dr. Richard Weleber's group at the Oregon Health & Science Uni-
versity (http://www.ohsu.edu/xd/health/services/casey-eye/research/
ushersyndrome-study.cfm). This clinical trial is still ongoing and results
are yet unpublished.
7.4. Other therapeutic approaches
Translational read-through small molecule drugs for nonsense mu-
tations and genome editing are two approaches with no necessity to
pack large genes into a viral vector and no risk of mutagenesis caused
by random insertion of viral vectors into the host genome. These two
approaches are also able to keep intact the endogenous gene expression
regulatory machinery. Translational read-through drugs can insert a
random amino acid at the nonsense mutation site by changing mRNAconformation, thereby preventing translation premature stop. Among
these drugs, molecules NB54 and PTC124 have been tested to suppress
a nonsense mutation, p.R31X, of the USH1C gene in vivo [187].
Subretinal injection of NB54 and PTC124 is able to restore protein
expression of full-length harmonin in mice. However, the amount of
corrected harmonin protein relative to its endogenous protein level
was not reported, and the ability of PTC124 to read through the prema-
ture stop codon was recently challenged [188]. On the other hand,
genome editing is a newly emerging technique to correct gene muta-
tions at the genomic DNA level using artiﬁcially-engineered nucleases
[189–191]. Two zinc-ﬁnger nucleases, designed for different cutting
sites around the p.R31X mutation of USH1C, are able to correct the
DNA error through homologous recombination with a normal DNA
template and eventually induce full-length harmonin protein expres-
sion without affecting cell viability in cultured cells [192]. At present,
this technique is untested in the retina of animal models.
Despite these encouraging ﬁndings with translational read-through
drugs and genome editing, limitations exist with both approaches. If
successful in clinical trials, the translational read-through drugs can
only be applied to treat patients carrying nonsense mutations in USH
genes, which account for only ~12% of all USH mutations [193]. The
genome editing technique has been investigated mainly to correct
mutations ex vivo in induced pluripotent stem cells (iPSCs), which are
eventually returned to the affected tissue of same patients where the
iPSCs are derived [189–191]. Up to now, only two studies have
attempted to edit genome in vivo by directly delivering engineered
nucleases into the mouse liver [194,195]. One showed some success in
correcting the mutant gene, generating a small amount of normal pro-
tein and partially rescuing the phenotype [194]. Therefore, for future
clinical application of genome editing in USH patients, direct ways to
deliver engineered nucleases and DNA templates into photoreceptors
and hair cells need to be explored. As genome editing is subject to off-
target toxicity and low efﬁciency problems [189–191,194], the mecha-
nisms underlying genome editing need to be elucidated in detail.
8. Current gaps in understanding and treating USH
Despite identiﬁcation and extensive study of USH genes using
various biochemical, cellular and genetic approaches, knowledge of
gene functions at the molecular level is far from full elucidation, espe-
cially in the retina, which poses a major hurdle for us to understand
the pathogenic mechanisms of USH. The major reason is that pheno-
types observed in retinas of USH patients are not faithfully replicated
in mice, the historically gold standard animal model for studying
human diseases. Several explanations were discussed previously [22,
196]. Recently, more hypotheses have been proposed. One is that
human and mouse photoreceptors have different subcellular structural
requirements for their survival. Localization of USH1 proteins in human
photoreceptor calyceal processes [105] and the retinal degeneration
symptoms manifested in USH1 patients suggest that calyceal processes
are essential for human photoreceptor survival. However, the absence
of real calyceal processes and unclear localizations of USH1 proteins in
mouse photoreceptors implies that this structure and USH1 proteins
are dispensable for rodent photoreceptor survival. Another hypothesis
is that USH genes are expressed and required differently for human
and animal photoreceptor survival. For instance, expressions of primate
CDH23 and mouse Cdh23 isoforms are not the same in the retina [101].
Further, cadherin 23, harmonin and clarin-1 proteins of various species
show signiﬁcantly different retinal cellular and subcellular patterns [97,
99,112,114,115,118,119]. A third hypothesis is that light illumination is
necessary to induce retinal degeneration in USH mouse models [153,
160], although the underlyingmechanism is unclear. Recently, zebraﬁsh
models carrying USH gene mutations have emerged to exhibit early
retinal degeneration phenotypes, such as myo7aaty229d/ty229d and
ush1cfh293/fh293 zebraﬁsh [115,151], indicating that zebraﬁsh models
could be useful for understanding functions of USH genes in the retina
416 P. Mathur, J. Yang / Biochimica et Biophysica Acta 1852 (2015) 406–420and testing potential treatments. However, evolutionary distance of
zebraﬁsh from humans and duplication of human gene orthologs may
pose problems, when ﬁndings in zebraﬁsh are interpreted and applied
to humans. Therefore, development of animal models exhibiting retinal
characteristics similar to USH patients is of prime importance.
Current knowledge of USH genes in the vestibular system is scarce.
Direct assessment of vestibular function in humans is challenging in
terms of both techniques and patients' experience [197]. Furthermore,
additional contribution of eyes and proprioceptive organs to balance
maintenance [3,198] may mask balance problems in USH patients.
These factors possibly lead to research more focused on the cochlea/
hearing than the vestibular system/balance. But USH1 and some USH3
patients usually experience more severe balance problems when their
vision deteriorates with age. Considering the potential differences of
USH multiprotein complexes across different tissues, investigation of
USH genes in vestibular organs should be strengthened.
Many case reports on USH patients showing mental disorders exist
in the literature [199–211]. Two recent reports also imply that usherin
and whirlin may be associated with other sensory modalities, touch
and pain [164,167]. Thus, these reports raise a question whether USH
patients may have other symptoms in addition to hearing, vision and
balance abnormalities. However, all these reports have a limitation
due to small sample sizes of patients and mice examined. Further
well-designed studies to evaluate the mental health and other senses
in USH patients need to be considered.
Therapeutic approaches, such as viral-mediated gene replacement,
ASO therapy, translational read-through chemical drugs and genome
editing, have been actively explored, while therapeutic research using
various types of stem cells is relatively stagnant. Most approaches
are now targeted to rescue either hearing or vision loss but not both.
Except the cochlear implantation and EIAV-based lentiviral-mediated
replacement of the MYO7A gene, other approaches are still in their
early stage in terms of eventual application in USH patients. Finally,
further investigation into the genotype–phenotype correlations of
USH genes and elucidation of their molecular basis are imperative for
early and appropriate diagnosis, genetic counseling, prognosis and
therapy as well as for comprehensive understanding of the USH gene
functions in vivo.9. Summary
USH is an incurable autosomal recessive genetic disease. USH
patients exhibit various degrees of hearing, vision and balance
impairment. Currently, thirteen genes have been identiﬁed to be associ-
atedwithUSH. These genes encode proteins believed to conduct various
cellular functions, including intracellular transport, organization of
multiprotein complexes, cell adhesion and cell signaling. The USH
proteins probably function in multiprotein complexes in vivo. Although
required for the development, maintenance and function of hair cell
stereocilia in the inner ear, USHmultiprotein complexes are not well re-
vealed at themolecular level, and understanding of diseasemechanisms
underlying USH is incomplete. At present, progress is being made
actively to develop effective treatments for USH.Acknowledgements
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